Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience. (2017). Archivio Italiano Di Urologia E Andrologia, 89(4), 272-276. https://doi.org/10.4081/aiua.2017.4.272